Holding(s) in Company
March 24 2010 - 12:21PM
UK Regulatory
TIDMGWP TIDMPRU
RNS Number : 1426J
GW Pharmaceuticals PLC
24 March 2010
+----------------+--------------------+--+----+---------------+---------------+--------+
| TR-1 NOTIFICATION OF MAJOR INTEREST IN SHARES |
| |
+--------------------------------------------------------------------------------------+
| 1. Identity of the issuer or the underlying | GW Pharmaceuticals |
| issuer | |
| of existing shares to which voting rights | |
| are | |
| attached: | |
+---------------------------------------------+----------------------------------------+
| 2 Reason for the notification (please tick the appropriate box or boxes): |
+--------------------------------------------------------------------------------------+
| An acquisition or disposal of voting rights | X |
+-----------------------------------------------------------------------------+--------+
| An acquisition or disposal of qualifying financial instruments which may | |
| result in the acquisition of shares already issued to which voting rights | |
| are attached | |
+-----------------------------------------------------------------------------+--------+
| An acquisition or disposal of instruments with similar economic effect to | |
| qualifying financial instruments | |
+-----------------------------------------------------------------------------+--------+
| An event changing the breakdown of voting rights | |
+-----------------------------------------------------------------------------+--------+
| Other (please | | |
| specify): | | |
+----------------+------------------------------------------------------------+--------+
| 3. Full name of person(s) subject | Prudential plc group of companies |
| to the | |
| notification obligation: | |
+-------------------------------------+------------------------------------------------+
| 4. Full name of shareholder(s) | See attached schedule |
| (if different from 3.): | |
+-------------------------------------+------------------------------------------------+
| 5. Date of the transaction and date | 23 March 2010 |
| on | |
| which the threshold is crossed or | |
| reached: | |
+-------------------------------------+------------------------------------------------+
| 6. Date on which issuer notified: | 24 March 2010 |
+-------------------------------------+------------------------------------------------+
| 7. Threshold(s) that is/are crossed | 11% to 12% |
| or | |
| reached: | |
+-------------------------------------+------------------------------------------------+
| | | | | | |
+----------------+--------------------+--+----+---------------+---------------+--------+
+--------------+---------+----+------+----------+--------+---+--+--------------+-+------+-----+----------+-----+-------------+----+--+----------+
| 8. Notified details: |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| A: Voting rights attached to shares |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| Class/type | Situation previous | Resulting situation after the triggering transaction |
| of | to the triggering | |
| shares | transaction | |
| if | | |
| possible | | |
| using | | |
| the ISIN | | |
| CODE | | |
+ +------------------------------------------------+-------------------------------------------------------------------------------+
| | Number | Number | Number | Number of | % of voting rights |
| | of | of | of shares | voting | |
| | Shares | Voting | | rights | |
| | | Rights | | | |
+ + + +----------------+-----------------------+--------------------------------------+
| | | | Direct | Direct | Indirect | Direct | Indirect |
| | | | | | | | |
+--------------+---------------------+--------------------------+----------------+------------+----------+------------------------+-------------+
|GB0030544687 | 15,123,621 | 15,123,621 | 15,798,621 |15,798,621 | 0 | 12.18% | |
+--------------+---------------------+--------------------------+----------------+------------+----------+------------------------+-------------+
| | | | | | | | |
+--------------+---------------------+--------------------------+----------------+------------+----------+------------------------+-------------+
| |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| B: Qualifying Financial Instruments |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| Type of financial | Expiration | Exercise/ | Number of voting | % of voting |
| instrument | date | Conversion Period | rights that may be | rights |
| | | | acquired if the | |
| | | | instrument is | |
| | | | exercised/ | |
| | | | converted. | |
+-----------------------------+--------------------------+------------------------------+------------------------------------+------------------+
| | | | | |
+-----------------------------+--------------------------+------------------------------+------------------------------------+------------------+
| |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| Type of | Exercise price | Expiration | Exercise/ | Number of voting | % of voting rights |
| financial | | date | Conversion | rights instrument | |
| instrument | | | period | refers to | |
| | | | | | |
+------------------------+----------------------+------------+-------------------+-----------------------------+--------------------------------+
| | | | | | Nominal | Delta |
| | | | | | | |
+ + + + + +---------------------+----------+
| | | | | | | |
+------------------------+----------------------+------------+-------------------+-----------------------------+---------------------+----------+
| |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| Total (A+B+C) |
+-----------------------------------------------------------------------------------------------------------------------------------------------+
| Number of voting rights | Percentage of voting rights |
+------------------------------------------------------------------------------+----------------------------------------------------------------+
| 15,798,621 | 12.18% |
+------------------------------------------------------------------------------+----------------------------------------------------------------+
| | | | | | | | | | | | | | | | | | |
+--------------+---------+----+------+----------+--------+---+--+--------------+-+------+-----+----------+-----+-------------+----+--+----------+
+--------------------------------------+-----------+------------------------------+
| 9. Chain of controlled undertakings through which the voting rights and/or the |
| financial instruments are effectively held, if applicable: |
+---------------------------------------------------------------------------------+
| Prudential plc (parent Company) |
| M&G Group Limited (wholly owned subsidiary of Prudential plc) |
| M&G Limited (wholly owned subsidiary of M&G Group Limited) |
| M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) |
| M&G Securities Limited (wholly owned subsidiary of M&G Limited) |
| |
+---------------------------------------------------------------------------------+
| |
+---------------------------------------------------------------------------------+
| Proxy Voting: |
+---------------------------------------------------------------------------------+
| 10. Name of the proxy holder: | N/A |
+--------------------------------------------------+------------------------------+
| 11. Number of voting rights proxy holder will | N/A |
| cease | |
| to hold: | |
+--------------------------------------------------+------------------------------+
| 12. Date on which proxy holder will cease to | N/A |
| hold | |
| voting rights: | |
+--------------------------------------------------+------------------------------+
| |
+---------------------------------------------------------------------------------+
| 13. Additional information: | |
| | |
+--------------------------------------+------------------------------------------+
| 14. Contact name: | Dipesh Varsani / Mark Thomas |
| | M&G Investment Management Limited |
+--------------------------------------+------------------------------------------+
| 15. Contact telephone number: | 020 7548 3261 / 020 7548 3266 |
+--------------------------------------+------------------------------------------+
| | | |
+--------------------------------------+-----------+------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXDLAFXEEFF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles